Foley Partner Jacqueline Wright Bonilla was quoted in an article that appeared in FDA Week on August 5, 2011 titled “Gene Patent Ruling’s Isolation v. Purification Distinction Could Impact Biotech.” Wright Bonilla discusses a federal court ruling on DNA patent eligibility that distinguishes between the terms isolation and purification. She states that the distinction is not clearly defined with regards to non-nucleic acid biologics and pharma molecules, adding that this distinction might be determined on a product-by-product basis and influence how attorneys draft their patent claims.
Related News
04 October 2024
In the News
Rajiv Dharnidharka and Jeanette Barzelay Featured Across Legal Press for Move to Foley
Recent laterals Rajiv Dharnidharka and Jeanette Barzelay are featured across legal press for their arrival to Foley, including in the Law360 article, "Foley Adds 2 DLA Piper Business Litigators In San Francisco."
04 October 2024
In the News
Chanley Howell on AI IP Protection in Litigation – 'Judges are human'
Foley & Lardner LLP partner Chanley Howell shared insight on protecting the intellectual property behind emerging technologies like artificial intelligence in the Bloomberg Law article, "AI Put on Trial in ‘Life or Death’ Police Tech Clashes."
01 October 2024
In the News
Natasha Allen on DEI Challenges for Corporate Boards – 'Diversity is necessary for companies to succeed'
Foley & Lardner LLP partner Natasha Allen authored the article, "Navigating Today's DEI Challenges," in the November/December issue of Corporate Governance Advisor.